News & AnalysisPyramid Biosciences nets $28mBoston-based Pyramid Biosciences Inc, a biotech company, has raised $28 million in funding.ByIris Dorbian1 September 2020•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs